100 Percent Fed Up noted last weekend that Mayo Clinic, one of the top-ranked medical institutions in the United States, quietly made a new statement about hydroxychloroquine.

Mayo Clinic Makes Hydroxychloroquine Admission

“Hydroxychloroquine may also be used to treat coronavirus (COVID-19) in certain hospitalized patients,” Mayo Clinic stated on its website.

This is what Mayo Clinic said about hydroxychloroquine on its website a few days ago.

Hydroxychloroquine is used to treat malaria. It is also used to prevent malaria infection in areas or regions where it is known that other medicines (eg, chloroquine) may not work. Hydroxychloroquine may also be used to treat coronavirus (COVID-19) in certain hospitalized patients.

Using this medicine alone or with other medicines (eg, azithromycin) may increase your risk of heart rhythm problems (eg, QT prolongation, ventricular fibrillation, ventricular tachycardia). Hydroxychloroquine should only be used for COVID-19 in a hospital or during clinical trials. Do not take any medicine that contains hydroxychloroquine unless prescribed by your doctor.


Hydroxychloroquine belongs to a group of medicines known as antimalarials. It works by preventing or treating malaria, a red blood cell infection transmitted by the bite of a mosquito. However, this medicine is not used to treat severe or complicated malaria.

Hydroxychloroquine is used to treat discoid lupus erythematosus (DLE) or systemic lupus erythematosus (SLE or lupus). It is also used to treat acute and chronic rheumatoid arthritis.

This medicine is available only with your doctor’s prescription.

However, you’ll notice the above link currently doesn’t share the same information.

The Mayo Clinic link now reads:

Hydroxychloroquine is not recommended as a treatment for coronavirus disease 2019 (COVID-19). Also, hydroxychloroquine doesn’t prevent infection with the virus that causes COVID-19.

In March 2020, the U.S. Food and Drug Administration, also called the FDA, allowed emergency use of hydroxychloroquine and chloroquine to treat COVID-19. The FDA based this authorization on data collected from healthcare professionals and tests done on cell lines, not humans.

The FDA also began tracking the health of people taking these medicines.

In April 2020, the FDA warned healthcare professionals against using hydroxychloroquine and chloroquine to treat COVID-19 unless people were in the hospital or a clinical trial. Data collected by the FDA found heart problems at a higher rate among people taking these medicines compared with those who didn’t take them.

In June 2020, the FDA ended the emergency use of hydroxychloroquine and chloroquine for treatment of COVID-19.

Over time, clinical trials showed hydroxychloroquine:

  • Led to serious heart problems in some people.
  • Did not effectively treat COVID-19.
  • Did not prevent infection with the virus that causes COVID-19.

Zero Hedge, one of the outlets that discovered the conflicting information, shared both versions in this post.


*Image from Zero Hedge X Post*

Zero Hedge reports:

Now, the Mayo Clinic redirects people to a “safe” page.

Of course, pro-vax (we assume) outlets pounced on the fact that this information has been there since at least May of 2020.

Which means… by the transitive properties of woke outrage, the Mayo clinic has been spreading misinformation for three years? Cancel them!

Meanwhile, an analysis of dozens of studies on Hydroxychloroquine and COVID-19 reveals a 72% lower mortality risk when taken early, and a 41% lower mortality risk when given early into hospitalization (when both HCQ and Ivermectin are known to be less effective vs. at first symptoms).

Join The Conversation. Leave a Comment.

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.